Location History:
- Dallas, TX (US) (2017)
- Coppell, TX (US) (2014 - 2023)
Company Filing History:
7 out of 5,469 
1 out of 271 
Years Active: 2014-2023
Title: Jiaxin Hu: Innovator in Genetic Research and Treatment
Introduction
Jiaxin Hu is a prominent inventor based in Coppell, Texas, known for her significant contributions to genetic research and therapeutic methods. With a total of seven patents to her name, she has made remarkable strides in addressing critical health issues, particularly in the fields of neurology and ophthalmology.
Latest Patents
Among her latest patents is the invention titled "Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAs targeting the expanded hexanucleotide repeat." This patent provides compositions and methods aimed at reducing the expression of C9orf72 transcripts in cells that contain expanded intronic GGGGCC regions. This innovation is particularly relevant for individuals who are at risk of developing amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Another notable patent is related to the "Treatment of Fuchs' endothelial corneal dystrophy," which describes compounds and methods useful in treating this specific eye condition.
Career Highlights
Jiaxin Hu has worked with esteemed organizations such as the University of Texas System and Ionis Pharmaceuticals, Inc. Her work in these institutions has allowed her to develop and refine her innovative ideas, contributing to advancements in medical science.
Collaborations
Throughout her career, Jiaxin has collaborated with notable professionals in her field, including David R. Corey and Masayuki Matsui. These partnerships have further enhanced her research and development efforts.
Conclusion
Jiaxin Hu's contributions to genetic research and treatment exemplify her dedication to improving health outcomes through innovation. Her patents reflect her commitment to addressing complex medical challenges, making her a significant figure in her field.